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ABSTRACT 
Drug permeation through the intercellular lipids, which pack around and between 
corneocytes, may be enhanced by increasing the thermodynamic activity of the 
active in a formulation. However, this may also result in unwanted drug crystallisation 
on and in the skin. In this work, we explore the combination of ATR-FTIR 
spectroscopy and multivariate data analysis to study drug crystallisation in the skin.  
Ex vivo permeation studies of saturated solutions of diclofenac sodium (DF Na) in 
two vehicles, propylene glycol (PG) and dimethyl sulphoxide (DMSO), were carried 
out in porcine ear skin. Tape stripping and ATR-FTIR spectroscopy were conducted 
simultaneously to collect spectral data as a function of skin depth. Multivariate data 
analysis was applied to visualise and categorise the spectral data in the region of 
interest (1700 – 1500 cm-1) containing the carboxylate (COO-) asymmetric stretching 
vibrations of DF Na.  
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Spectral data showed the redshifts of the COO- asymmetric stretching vibrations for 
DF Na in the solution compared with solid drug. Similar shifts were evident following 
application of saturated solutions of DF Na to porcine skin samples. Multivariate data 
analysis categorised the spectral data based on the spectral differences and drug 
crystallisation was found to be confined to the upper layers of the skin.  
This proof-of-concept study highlights the utility of ATR-FTIR spectroscopy in 
combination with multivariate data analysis as a simple and rapid approach in the 
investigation of drug deposition in the skin. The approach described here will be 
extended to the study of other actives for topical application to the skin. 
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CHEMICAL COMPOUNDS STUDIED IN THIS ARTICLE 
Diclofenac sodium (PubChem CID: 5018304); Dimethyl sulphoxide (PubChem CID: 
679); Propylene glycol (PubChem CID: 1030) 
 
ABBREVIATION 
ATR-FTIR Attenuated total reflectance Fourier transform infrared 
DF Na  Diclofenac sodium  
DMSO Dimethyl sulphoxide 
HCA  Hierarchical cluster analysis 
IR  Infrared 
PC(s)  Principal component(s) 
PCA  Principal component analysis 
PG  Propylene glycol  
PLM  Polarised light microscopy 
SC  Stratum corneum 
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1. INTRODUCTION 
Supersaturation is a passive enhancement strategy which may be used to promote 
drug penetration across the skin [1]. It is achieved by loading an excess amount of 
drug in a formulation so that it exceeds its solubility limit. As this method implicitly 
increases the thermodynamic activity of a molecule, this creates an unstable state of 
the active and may result in crystallisation on and in the skin. Once crystallisation is 
initiated, drug is “stranded” in the skin with a consequent reduction in flux. Santos 
and coworkers have previously suggested that drug crystallisation contributed to the 
lack of permeation enhancement observed for supersaturated oxybutynin and 
fentanyl formulations [2-4]. Solvent depletion was also proposed in these studies as 
the primary driving force for drug crystallisation in the skin. Saar et al. [5] showed the 
formation of ibuprofen crystals on excised mouse skin using simulated Raman 
scattering (SRS) imaging, following application of a solution of deuterated ibuprofen 
in propylene glycol (PG). More recently, Belsey et al. [6] observed large ibuprofen 
crystals on porcine skin 30 min post application of a saturated solution of ibuprofen 
in PG using the same imaging technique. However, actual location of crystals in the 
skin remains a limitation of SRS imaging as is the apparent requirement for 
deuteration of the active of interest. 
Depending on the active of interest, infra-red spectroscopy may allow a distinction to 
be made between the solid and solution forms. A modification of IR, Attenuated Total 
Reflectance Fourier Transform IR (ATR-FTIR), has previously been used for 
simultaneous monitoring of skin permeation of actives and vehicle components [7-
11]. Because of the complexity of the spectral datasets which are typically collected, 
multivariate data analysis is a very useful tool to study subtle differences in IR 
spectra. Hierarchical cluster analysis (HCA) and principal component analysis (PCA) 
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have both been used to classify spectroscopic results based on their dissimilarity 
and variations [12]. 
Our approach in this proof-of-concept study is to demonstrate a rapid and simple 
experimental setup using ATR-FTIR spectroscopy to examine drug crystallisation in 
the skin. Simple formulations of diclofenac sodium (DF Na) in two different 
penetration enhancers – PG or dimethyl sulphoxide (DMSO) were applied to porcine 
skin samples. Diclofenac is a potent nonsteroidal anti-inflammatory drug (NSAID) for 
general treatment of pain and inflammation. It is usually formulated as salt forms 
such as diclofenac sodium or potassium as a strategy to improve the solubility and/or 
stability. Various approaches to enhance the skin penetration of diclofenac have 
been reviewed in a previous publication [13]. Santos et al. [2-4] previously suggested 
that PG may promote drug crystallisation in the skin and DMSO is also known to 
induce the formation of steroid reservoirs in the skin [14]. 
 
2. MATERIALS AND METHODS 
2.1.  Materials 
Diclofenac sodium (DF Na) was purchased from AK Scientific Inc. (Union City, CA, 
US). PG and DMSO were obtained from Sigma-Aldrich (Gillingham, UK). 
Hydrochloric acid (1M) was obtained from Alfa Aesar (Ward Hill, MA, US). Sodium 
chloride and sodium hydroxide were supplied by VWR International Ltd. (Lutterworth, 
UK) and Fischer Scientific (Loughborough, UK). A Bradford protein assay kit was 
obtained from Sigma-Aldrich (Gillingham, UK). Scotch packaging tape (3M, St. Paul, 
MN, US) was obtained from a local stationery store. HPLC grade water, methanol, 
acetonitrile and trifluoroacetic acid (TFA) were obtained from Fischer Scientific 
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(Loughborough, UK). Full thickness porcine skin tissues were isolated from porcine 
ear skin obtained from a local abattoir and were stored at -20ºC before use.  
 
2.2. Preparation of saturated solutions of DF Na 
Saturated solutions of DF Na were prepared by adding excess DF Na to PG and 
DMSO followed by agitation of the solutions in an oven for 48 h at 32 ± 1ºC [15, 16]. 
The solutions were centrifuged to obtain supernatant for solubility determination 
using HPLC. 
 
2.3. Ex vivo permeation studies and tape stripping using porcine 
ear skin 
An infinite dose (95 µL/cm2) of the DF Na solution was applied to a delineated area 
of porcine ear skin (7.5 × 1.5 cm) for 1 h at room temperature. This dosing area is 
slightly larger than the dimensions of the ATR zinc selenide (ZnSe) crystal (7.2 × 1.0 
cm2). The area was not occluded in order to maximise the possibility of drug 
crystallisation. Gauze was cut to the same size of the dosing area before application 
of solutions to ensure no spreading beyond the delineated areas. After 1 h, the 
gauze was removed and the sites were gently wiped with dry tissues to remove 
excess solution before tape stripping. The skin was then held firmly using pins on a 
cork board overlaid with a piece of Parafilm® before tape stripping. The sequential 
removal of SC via tape stripping was carried out using Scotch packaging tape. A 
plastic template with a rectangular aperture (~8 × 2 cm2) was used to ensure all 
crystals which might be present on the skin surface could be recovered from the 
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sample site. Twenty sequential tapes were obtained in each set of experiments for 
the tape stripping procedure. The direction of tape removal was alternated in order to 
achieve more uniform stripping of the SC [17, 18]. This ex vivo tape stripping 
procedure was standardised in terms of intensity by using a 10 cm long lint roller 
(Primark, Reading, UK) and the speed of tape stripping was monitored to ensure 
reproducibility. 
 
2.4. ATR-FTIR spectroscopy 
2.4.1. Spectra collection for solid and solution forms of DF Na 
A FTIR spectrometer (Tensor 27; Bruker Optics Ltd., Coventry, UK) with a Specac™ 
multi-bounce (25 reflection, 45º, refractive index of 2.40) ATR accessory (Specac 
Ltd., Orpington, UK) – ZnSe (7.2 × 1.0 cm2), was used to collect the reference 
spectra for the solid form of DF Na (ethanolic paste), DF Na in PG (200 mg/mL) and 
DMSO (100 mg/mL). The ethanol paste of DF Na was prepared by mixing a minimal 
amount of ethanol with DF Na powder. This paste was then spread evenly on the 
ZnSe crystal and allowed to dry for about half an hour before collecting spectra [7]. 
For analysis of solutions, an aluminum slab was used to form a reservoir using 
vacuum grease. For each sample 32 scans were collected with a resolution of 4 cm-1 
in the range of 4000 cm-1 to 600 cm-1. The spectra collected were analysed using 
Opus software version 6.0 (Bruker Optics Ltd., Coventry, UK) and OriginPro 9.0.0 
(OriginLab Corp., Northampton, MA, US). 
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2.4.2. Spectra collection during tape stripping 
The ATR-FTIR spectrum of porcine ear skin as a control was obtained before 
application of DF Na solutions to ensure no chemical contamination. The skin was 
placed in contact with the ZnSe crystal (SC facing downward) with a constant 
pressure under a weight (100 mg) to establish close contact before spectral 
collection. After 1 h of application of the samples to the skin a further spectrum was 
collected before tape stripping. The subsequent FTIR spectra collection were carried 
out simultaneously with the tape stripping procedure. For every tape stripping step, 
FTIR spectra were collected for both the tape strip and stripped skin. In order to 
ensure good contact with the surface of the ZnSe crystal, the tape strip was adhered 
firmly (adhesive part facing down) and trapping of air was avoided. The stripped skin 
was placed in close contact with a constant pressure. The surface of the ZnSe 
crystal and its holder were cleaned with ethanol to avoid cross contamination 
between scans. Three replicates were conducted for each saturated solution. These 
steps were repeated for the control study without any treatment, and also for 
treatment with the neat solvents (95 µL/cm2). 
 
2.5. Polarised light microscopy (PLM) 
Tape strips were observed using a polarised light microscope (Leica DM L52, 
Germany). The images were captured using an INFINITY2 digital camera and 
INFINITY2 software (Lumenera Corp., Ontario, Canada) at 5× magnification. 
Studio86 Design capture software (Lutterworth, UK) was used to collect the images. 
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2.6. Extraction and analysis of DF Na in the tapes 
The content of DF Na was quantified from each tape strip by extraction in methanol 
overnight. The tape strip was cut into smaller pieces and placed in a 2 mL eppendorf 
tube containing 1 mL of methanol. A second extraction was carried out with an equal 
volume of methanol. The extracts were suitably diluted and analysed using HPLC. 
The extraction was performed in triplicate. The method was validated by spiking 
tape-stripped samples of untreated SC with known amounts of DF Na in PG or 
DMSO with more than 95% recovery (data not shown).  
 
2.7. HPLC analysis  
DF Na was quantified using an Agilent 1100 Series G1311A quaternary pump 
(Hewlett Packard, Santa Clara, CA, US), set at a flow rate of 1.2 mL/min, with a 
G1315B Diode Array Detector set at 277 nm. The stationary phase was a Shiseido 
Capcell Pak C18 5 µm column (250 x 4.6 mm) (Tokyo, Japan) attached to a 
SecurityGuard™ guard column with C18 cartridge (Phenomenex, Macclesfield, UK). 
The mobile phase was 70% acetonitrile, 30% water and 0.1% TFA. Samples were 
injected via a 25 µL loop and the retention time was 4.8 min. The HPLC method was 
developed and validated according to the ICH guideline Q2(R1) [19]. The lower limits 
of detection and quantification for DF Na were 0.1 and 0.5 µg/mL, respectively.  
 
2.8. Bradford protein assay 
The protein content of porcine SC removed with each tape strip for untreated porcine 
skin was quantified using the Bradford protein assay (micro 2 mL assay protocol, 
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Technical bulletin Catalog Number B6919). The Bradford protein assay is pH 
sensitive and the readings were clearly affected by the presence of PG or DMSO. 
The tape strips were cut into small pieces before transfer to 10 mL scintillation vials. 
A volume of 4 mL of 1 M sodium hydroxide solution was added to extract the protein. 
The amount of sodium hydroxide was four times the quantity previously used to 
extract protein from porcine SC for an area of ~ 4 cm2 using D-Squame® and 
Corneofix® tapes [20]. These vials were then shaken at 37ºC for 1 h and sonicated 
for 30 – 60 min at room temperature to fully extract the proteins. A 500 µL aliquot of 
solution was transferred to 2 mL Eppendorf tubes and neutralised with an equal 
volume of 1M hydrochloric acid. After vortexing for 5 – 10 s, 250 µL of neutralised 
samples were transferred to 2 mL Eppendorf tubes and diluted with 750 µL 1M 
sodium chloride. Subsequently, 1 mL of Bradford reagent was added to each tube. 
The absorbance of the samples at 595 nm was determined at room temperature with 
a Biomate 3 UV/Vis Spectrophotometer (Thermo Spectronic, Rochester, NY, US). A 
blank tape served as a control and was extracted in a similar manner as for the 
tapes containing protein for each set of experiments. The protein content was 
determined based on a calibration curve developed using freshly prepared SC 
standard solutions in the concentration range 0 – 500 µg/mL [21]. In order to ensure 
all protein was solubilised in sodium hydroxide after one extraction, the tapes were 
removed for a second extraction with sodium hydroxide and quantified using the 
same method. 
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2.9. Multivariate data analysis  
The FTIR spectra in the 1700 – 1500 cm-1 region were selected for study because 
this range contains characteristic bands of the diclofenac molecule, namely 
carboxylate (COO-) asymmetric stretching vibrations. Preprocessing of spectral data 
was performed by standardisation (normalisation to z score). Normalisation is 
important for dissimilarity or distance measurement such as the Euclidean distance 
which is sensitive to the differences within the magnitude or scales of the variables 
[22]. It also helps to compensate for the differences in sample quantity or a different 
optical pathlength and improves accuracy and efficiency of the data models [23-25]. 
Hierarchical cluster analysis (HCA) and principal component analysis (PCA) were 
performed using OriginPro 9.0.0 (OriginLab Corp., Northampton, MA, US). The 
dissimilarity of spectra in HCA was measured by the Euclidean distance to generate 
a dendrographic classification. PCA was represented by a score plot and the 
corresponding PCs which explain more than 90% of total variance. 
 
3. RESULTS  
3.1. Saturated solubility of DF Na 
The saturated solubility of DF Na in PG at 32ºC was determined to be 386 ± 18 
mg/mL and the corresponding value in DMSO was 149 ± 9 mg/mL. The solubility of 
DF Na in DMSO is consistent with the concentration estimated from the solubility 
graph of DF Na (~ 165 mg/g) reported by Žilnik et al. [26].  
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3.2. ATR-FTIR spectra of DF Na in solid and solution forms 
The ATR-FTIR spectrum of DF Na (ethanolic paste) is shown in Figure 1A. The 
carboxylate (COO-) functional group shows asymmetric stretching vibrations in the 
1610 – 1560 cm-1 region. The presence of an aromatic ring also contributes to the 
C=C stretching vibrations near 1500 – 1400 cm-1. A broad absorption band around 
3700 – 3000 cm-1 is attributed to N–H and O–H stretching vibrations.  
Figure 1B shows the standardised ATR-FTIR spectra of DF Na in different forms – 
solid ethanolic paste, solutions of DF Na in PG (200 mg/mL) or DMSO (100 mg/mL). 
The ATR-FTIR spectra for unsaturated drug solutions were collected for comparison 
as the saturated drug solutions tended to crystallise rapidly. When DF Na is 
dissolved in the selected penetration enhancers, the ATR-FTIR spectra are similar to 
those of the penetration enhancers alone apart from the 1700 – 1500 cm-1 region. 
Peak shifts were observed for the COO- asymmetric stretching vibrations, from 1576 
cm-1 to 1578 cm-1 and from 1557 cm-1 to 1560 cm-1, when DF Na was dissolved in 
PG (Figure 1B I). However, these peak shifts were not evident when DF Na was 
dissolved in DMSO. A new peak shift was observed from 1557 cm-1 to 1558 cm-1 and 
the shoulder of the peak at 1576 cm-1 was split as an additional peak at 1587 cm-1 
(Figure 1B II). These changes enable the differentiation of DF Na when it is fully 
dissolved in or is in the crystalline form. Therefore, ATR-FTIR spectra in the 1700 – 
1500 cm-1 range were selected for examination following application of DF Na 
solutions to skin. 
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3.3. ATR-FTIR spectra for tape stripping work 
Tape stripping on untreated skin was conducted concurrently with spectral collection 
for both stripped skin and tape strips containing SC. The standardised ATR-FTIR 
spectra in Figure 2 show the amide I and II bands of the SC. However, there are 
additional peaks in tape strips containing SC from the C=C stretching vibrations of 
the tape (polypropylene) near the 1650 – 1600 cm-1 region. 
With the application of neat PG or DMSO, the 1700 – 1500 cm-1 region was 
unaffected, except for peaks associated with protein (Figure 2). The amide I band 
provides information about the secondary structure of proteins in the skin [27]. An α-
helix protein conformation gives rise to a band in the range of 1647 – 1657 cm-1 
while a β-sheet structure is associated with the 1621 – 1640 cm-1 and 1671 – 1679 
cm-1 regions [28]. A shoulder near 1620 – 1630 cm-1 was observed for both PG- and 
DMSO-treated samples. This additional new feature suggested the formation of β-
sheet secondary protein structures [29, 30]. Modification of SC protein from the α-
helix to the β-sheet conformation by both PG and DMSO has also been reported by 
several researchers [31-34]. 
Changes in the amide bands of the SC were also evident following application of DF 
Na solutions (Figure 3). A new feature in these spectra was the COO- asymmetric 
stretching vibrations which indicate the presence of DF Na. This was observed at 
1576 cm-1 and 1557 cm-1 which represents the solid form of DF Na, following 
application of the saturated solution of DF Na in PG (Figure 3). However, weaker 
COO- asymmetric stretching vibrations were observed following the application of the 
solution of DF Na in DMSO. This may be related to the lower solubility of DF Na in 
DMSO compared with PG with no major changes in the ATR-FTIR spectra. In this 
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case, appearance of a peak at 1558 cm-1 in the region of COO- asymmetric 
stretching vibrations suggested the presence of the DF Na in solution. Considering 
the COO- asymmetric stretching vibrations indicating the DF Na in the solution under 
the influence of DMSO, multivariate data analysis was applied to further differentiate 
the spectra following application of saturated solutions of DF Na in PG only.  
 
3.4. Multivariate data analysis  
Multivariate data analysis was applied to deconvolute the standardised spectral data 
in the 1700 – 1500 cm-1 region. The statistical analysis was performed on the 
spectral data collected from stripped skin as there was strong interference from tape 
strips, especially in deeper skin layers. The spectra collected immediately after 
application of saturated solutions were excluded in this analysis (especially in 
principal component analysis, PCA) because the intensity of the COO- asymmetric 
stretching vibrations of DF Na was much higher than that of the amide peaks. This 
might reflect the presence of drug crystals on the skin surface, sandwiched between 
the ZnSe crystal and the skin, during spectral data collection; this would hinder the 
evanescent wave from reaching the skin. The presence of these spectra may also 
contribute to a reduced correlation for other datasets.  
Figure 4 shows dendrographic classifications (hierarchical cluster analysis, HCA), 
score plots and the first two principal components, PCs (PCA) for the standardised 
ATR-FTIR spectra in the 1700 – 1500 cm-1 region, for stripped skin, after application 
of DF Na in PG. The dissemblance of each data set allows the clustering of the 
spectral data based on the Euclidean distance as represented in the dendrogram, 
where two distinctive clusters were observed. In these dendrograms, the first two 
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observations, in most cases, were clearly distinguished from each other, showing a 
large difference in Euclidean distances between them (Figure 4A). This was also in 
agreement with the two-dimensional score plots obtained from PCA as shown in the 
same figure (Figure 4B). In PCA analysis, the first two PCs described more than 95% 
of the total variance observed. PC1 contains the highest source of variance for the 
data elements and completely describes the presence of DF Na as represented by 
the COO- asymmetric stretching vibrations (Figure 4C). Spectral data with significant 
spectral variations along PC1 were represented by the first cluster identified in the 
HCA. On the other hand, PC2, with the second highest variance, describes largely 
porcine SC and in part, background noise. This characterised the spectral data in the 
second cluster described in the HCA.  
Data clusters may be represented by a block model of SC with two different zones 
(Figure 5).  This diagram contains two zones: zone A – saturated solutions have 
permeated and crystals are present, and zone B – saturated solutions have 
permeated with minimal or no drug crystal formation. Zone A represents the spectral 
data grouped in the first cluster (red) in HCA and the first PC in PCA. This zone 
shows the presence of the COO- vibrations associated with solid DF Na. The second 
zone (B) is similar to the ATR-FTIR spectra of the SC (stripped skin) where there is 
no detection of DF Na or only to a minimal extent. Zone B contains the spectral data 
as defined in the second cluster (green) in HCA and the second PC in PCA. 
 
3.5. Polarised light microscopy (PLM) 
Figure 6 shows the PLM images of representative tape strips after application of 
saturated solutions of DF Na in PG and DMSO. Drug crystals were found to be small 
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and abundant with scattering on the first few tape strips. However, crystals were 
largely unobserved in the deeper layers of the SC (as evaluated using tape strip 
number). Nevertheless, these PLM images were consistent with evidence of drug 
crystallisation in the SC from the ATR-FTIR spectroscopy and multivariate data 
analysis. 
 
3.6. Depth profiles of DF Na in porcine ear skin 
The presence of DF Na in porcine ear skin was evaluated by extraction. Figure 7 
shows the amount of DF Na extracted from tape strips following application of DF Na 
in PG or DMSO. Despite a large concentration difference in the initial tapes, the 
remaining tapes contained comparable amounts of drug, irrespective of the solvent. 
In these depth profiles, the amount of DF Na was found to be higher for PG, 
especially for the first few tapes. The total amount of DF Na extracted from 20 tape 
strips after application of DF Na in PG was determined to be 5.0 ± 1.2 µg/cm2, 
almost twice the amount determined for DMSO (2.6 ± 0.5 µg/cm2).  This probably 
reflects the higher saturated solubility of DF NA in PG and is in good agreement with 
the results from the ATR-FTIR spectroscopic and microscopic imaging studies.  
 
3.7. Bradford protein assay 
The protein content of untreated porcine SC on tape strips was estimated using the 
Bradford protein assay. Knowing the tape stripped area (16 cm2), the SC thickness 
which reflects the depth of the SC barrier may be calculated assuming a value of 1 
g/cm3 for SC density [35]. This value is also similar to that for human SC density (0.8 
– 1.3 g/cm3) reported by Anderson and Cassidy [36]. Figure 8 shows the average 
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thickness of porcine SC removed by tape stripping. The total thickness of the SC 
removed from the 20 tape strips is estimated to be 7.7 ± 1.3 µm. Klang, et al. [20] 
estimated a total thickness of 7.96 ± 3.25 µm for SC removed from porcine skin 
using 80 – 130 tape strips but used a different type of tape. 
An attempt to mixing penetration enhancers and the Bradford reagent resulted in a 
significant change in the colour. This indicates the interference of additives such as 
penetration enhancers with the Bradford protein assay. Thus, determination of 
protein content in the tape strips after treatment with penetration enhancers and 
formulations was not carried out. The SC thickness for the experiments involving 
these two vehicles is assumed to be the same as the untreated SC. 
From the multivariate data analysis, it appears that drug crystals were present in ex 
vivo skin samples at a depth of 0.7 – 1.3 µm, which represents the superficial layers 
of the SC. 
 
4. DISCUSSION 
The phenomenon of drug crystallisation in percutaneous absorption has been 
suggested as one of the major factors compromising drug permeation over time. 
Several reports have shown the detection of drug crystals on mammalian skin but 
little is known about how the phenomenon actually happens in the skin [5, 6]. This 
study explored the combined abilities of (i) ATR-FTIR spectroscopy to detect drug 
crystals in skin samples and (ii) multivariate data analysis for differentiation of 
spectral characteristics descriptive of the physical state of the model drug. The 
important question addressed in this study is whether drug crystallisation does 
happen in the skin, specifically referring to the SC. 
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In this proof-of-concept study, drug crystals were found to be present in the 
superficial layers of the SC at a skin depth of 0.7 – 1.3 µm following topical 
application in PG. Even though drug extraction profiles showed the presence of drug 
in up to 20 tape strips, this observation does not differentiate crystalline DF Na and 
solubilised DF Na. Microscopic images, however, showed the presence of drug 
crystals on the tape strips for both saturated solution of DF Na in PG and DMSO but 
crystals were restricted to the first few layers of the SC. The microscopy 
observations are in line with the ATR-FTIR spectroscopic analysis of stripped skin for 
the application of DF Na in PG. The crystalline drug was detected only in the first two 
stripped skin samples using ATR-FTIR spectroscopy but not in the deeper layers of 
the SC. As drug is, in fact, expected to be present in small amounts in the deeper 
layers, the intensity of the COO- asymmetric stretching vibrations for crystalline DF 
Na will be relatively weaker compared with other components of the SC (protein and 
lipid). Considering the relatively weaker COO- asymmetric stretching vibrations in the 
deeper layers of the SC, the spectral data were subjected to multivariate data 
analysis to confirm the objective determination of the presence of theses vibrations 
in the spectra. Both hierarchical cluster analysis (HCA) and principal component 
analysis (PCA) successfully differentiated the spectral data into two distinct spectral 
groups with respect to the presence of COO- asymmetric stretching vibrations of the 
crystalline DF Na. More importantly, this statistical analysis complements the 
subjective observation of COO- asymmetric stretching vibrations present in the 
standardised spectra.  
On the other hand, no crystalline drug was detected when applied in DMSO for all 
ATR-FTIR spectroscopic analyses despite the fact that the crystalline form of the 
drug was seen in the microscopic images in the first few tape strips. The absence of 
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crystalline drug in the spectra following delivery in DMSO may be related to the 
sensitivity of the ATR-FTIR spectroscopy. From the drug extraction profiles (Figure 
7), drug content in each tape strip following application in DMSO is generally below 
0.5 µg/cm2. In this case, one might speculate that any drug crystals present in a tape 
strip containing an amount of drug less than 0.5 µg/cm2 are generally undetectable 
using ATR-FTIR spectroscopy. This might, therefore, be proposed as the lowest limit 
of detection of ATR-FTIR spectroscopy in this study with respect to the COO- 
asymmetric stretching vibrations of crystalline DF Na. This would also agree with the 
results obtained for the application of drug solution in PG. The first two tape strips 
containing more than 0.5 µg/cm2 of DF Na (Figure 7) showed the presence of COO- 
asymmetric stretching vibrations of crystalline DF Na. The rest of the tape strips 
containing less than 0.5 µg/cm2 of DF Na have no crystalline drug detected in the 
spectra, similar to all tape trips for the application of drug solution in DMSO. This 
result is also in line with the multivariate data analysis where the first two stripped 
skin samples were differentiated from the remaining samples based on these 
vibrations. 
Deposition of solid drug in the skin as observed in the study is expected to prevent 
further penetration of drug deeper into the skin. The poor efficiency of topical 
formulations due to the unwanted drug crystallisation may be related to the drug 
reservoir formation in the skin [37]. The potential to create a drug reservoir in the 
skin was previously observed by other researchers but the mechanism of drug 
reservoir formation remains unknown [14, 38, 39]. The present study indicates that 
drug crystallisation in the skin may contribute to the formation of drug reservoir in the 
skin. 
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The investigation of drug crystallisation in the skin should be considered for future 
development and design of topical and transdermal formulations. It is important to 
ensure that formulations allow rapid lateral and vertical diffusion of drugs and 
partition into the intercellular spaces [37]. At present, the residence time of most 
excipients used in topical formulations and their interactions with drugs and the skin 
has not been widely reported. Recent reports on the real time measurement of drug 
permeation in the skin using Confocal Raman Spectroscopy may provide further 
insight into the fate of drug following topical and transdermal application [40-42].  
 
5. CONCLUSIONS 
Drug crystallisation is expected to have significant implications for delivery of actives 
from topical formulations as noted earlier. This proof-of-concept study outlined a 
rapid and simple approach using ATR-FTIR spectroscopy to identify drug 
crystallisation occurred in the skin for simple formulations of DF Na. We also applied 
multivariate data analysis in deconvolution of spectral data to visualise and 
differentiate the spectral data containing drug crystals from the skin. This study 
showed that the depth to which crystals could be found ex vivo was around 0.7 – 1.3 
µm following topical application in a PG vehicle. Clearly, the technique may be 
applied to evaluate drug crystallisation behaviour for other actives used in topical 
formulations. We acknowledge that this is an ex vivo experimental set up but we will 
report validation of this approach in vivo with Confocal Raman Spectroscopy in 
future reports. 
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FIGURES 
 
Figure 1 (A) ATR-FTIR spectrum of DF Na pure drug powder (ethanolic paste) 
and (B) standardised ATR-FTIR spectra (1700 – 1500 cm-1) of DF Na pure drug 
powder (ethanolic paste), penetration enhancers – (I) PG and (II) DMSO and 
corresponding solutions of DF Na in PG (200 mg/mL) and DMSO (100 mg/mL) 
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Figure 2 Standardised ATR-FTIR spectra of stripped skin and tape strips with 
and without any application of penetration enhancers (PG and DMSO). * 
represents the spectrum taken before tape stripping started. 
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Figure 3 Standardised ATR-FTIR spectra of stripped skin and tape strips after 
application of the saturated solutions of DF Na in PG and DMSO (only the first 
ten spectra). * represents the spectrum taken before tape stripping started. 
Black and red dash lines are the wavenumbers recorded for the solid and 
solution form of DF Na, respectively.  
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Figure 4 (A) Dendrographic classifications from HCA, (B) corresponding score 
plots and (C) first two PCs from PCA of standardised ATR-FTIR spectra 
between 1700 and 1500 cm-1 for stripped skin after application of the saturated 
solution of DF Na in PG. The percentage of variance in the data explained by 
each PC is shown in brackets on each axis of the score plots. The number on 
the top left denotes the number of replicates. 
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Figure 5 Zones of stratum corneum (SC) assigned using multivariate data 
analysis. Zone A (red): area where saturated solutions permeated with a high 
potential for drug crystallisaton; Zone B (green): area where saturated 
solutions permeated with minimal or no potential for drug crystallisation. 
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Figure 6 PLM images (5×) of representative tape strips obtained from the 
application of the saturated solutions of DF Na in (A) PG and (B) DMSO (scale 
bar: 250 µm). Number on the top left of each image indicates the tape strip 
number.  
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Figure 7 Amount of DF Na in the tape strips removed after 1 h ex vivo 
permeation of saturated solutions of DF Na in PG and DMSO (n = 3, mean ± 
SD) 
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Figure 8 Average thickness of untreated porcine SC removed from 20 
sequential tape strips (n = 3, mean ± SD) 
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